This is supported by Ji et al. who observed that COX-2 was more expressed in ATC patients than in PTC patients by immunochemistry suggesting that high expression of COX-2 is correlated with thyroid cancer with poor prognosis (44). This evidence concerns the gene PTGS2 and thyroid gland carcinoma.